These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 3131029)

  • 41. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intermittent chemotherapy of pulmonary tuberculosis (review of the literature)].
    Utkin VV
    Probl Tuberk; 1978 Oct; (10):23-8. PubMed ID: 714901
    [No Abstract]   [Full Text] [Related]  

  • 43. [Should chemotherapy for pulmonary tuberculosis be started after the completion of pretreatment sputum examination?].
    Ito K; Aono A; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2005 Dec; 80(12):735-41. PubMed ID: 16447786
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chemotherapy of pulmonary tuberculosis. Sputum culture conversion in 8 weeks in 84% of patients].
    Nowak D; Radenbach D; Magnussen H
    Dtsch Med Wochenschr; 1987 Sep; 112(36):1367-70. PubMed ID: 3622281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of lymph node tuberculosis--a randomized clinical trial of two 6-month regimens.
    Jawahar MS; Rajaram K; Sivasubramanian S; Paramasivan CN; Chandrasekar K; Kamaludeen MN; Thirithuvathas AJ; Ananthalakshmi V; Prabhakar R
    Trop Med Int Health; 2005 Nov; 10(11):1090-8. PubMed ID: 16262733
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].
    Eule H; Beck H; Evers H; Fischer P; Kwiatkowski H; Merkel S; Reech R; Sieler R; Thomas E; Weinecke W
    Z Erkr Atmungsorgane; 1986; 167(1-2):29-41. PubMed ID: 3532585
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.
    Bartacek A; Schütt D; Panosch B; Borek M;
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):760-6. PubMed ID: 19460254
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 180 doses in 26 weeks vs 56 doses in 24 weeks of chemotherapy in pulmonary tuberculosis: a preliminary report.
    Jittinandana A; Kecharanandana P; Payanandana W; Daramas M
    J Med Assoc Thai; 1988 May; 71(5):238-43. PubMed ID: 2456361
    [No Abstract]   [Full Text] [Related]  

  • 50. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
    Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
    N Engl J Med; 1970 Sep; 283(12):616-21. PubMed ID: 4988918
    [No Abstract]   [Full Text] [Related]  

  • 51. [Sputum smear conversion during intensive TB treatment phase according to HIV status, in hospitalised patients in Togo].
    Wateba MI; Diop SA; Salou M; Womitso K; Nichols S; Tidjani O
    Med Mal Infect; 2011 Mar; 41(3):140-4. PubMed ID: 21282024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of a non-rifampicin continuation phase (6HE) following thrice-weekly intensive phase for the treatment of new sputum positive pulmonary tuberculosis.
    Indian J Tuberc; 2007 Apr; 54(2):84-90. PubMed ID: 17575680
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Dynamics of specific changes in recurrences of pulmonary tuberculosis in relation to chemotherapy schedules].
    Bobarykin VS
    Probl Tuberk; 1991; (10):53-5. PubMed ID: 1788233
    [No Abstract]   [Full Text] [Related]  

  • 54. [Reasons for chronic expectoration--case reports].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):244-8. PubMed ID: 9489422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Place of bacteriological examination in the treatment of tuberculosis].
    Gyselen A
    Acta Tuberc Pneumol Belg; 1972; 63(4):405-8. PubMed ID: 4206438
    [No Abstract]   [Full Text] [Related]  

  • 56. [Surgical treatment of patients with multi-resistant pulmonary tuberculosis--case reports].
    Michałowska-Mitczuk D; Kuś J
    Pneumonol Alergol Pol; 1997; 65(3-4):249-53. PubMed ID: 9489423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smear-negative, culture-positive pulmonary tuberculosis. Six-month chemotherapy with isoniazid and rifampin.
    Dutt AK; Moers D; Stead WW
    Am Rev Respir Dis; 1990 May; 141(5 Pt 1):1232-5. PubMed ID: 2111106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
    Dorman SE; Johnson JL; Goldberg S; Muzanye G; Padayatchi N; Bozeman L; Heilig CM; Bernardo J; Choudhri S; Grosset JH; Guy E; Guyadeen P; Leus MC; Maltas G; Menzies D; Nuermberger EL; Villarino M; Vernon A; Chaisson RE;
    Am J Respir Crit Care Med; 2009 Aug; 180(3):273-80. PubMed ID: 19406981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bacteriological examination on needle biopsy specimens of cavity and tuberculoma after a short course chemotherapy in initially sputum positive pulmonary tuberculosis patients].
    Lu SH; Wang TP; Lü W; Du RH; Wang HX; Wang ZR
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Dec; 29(12):832-4. PubMed ID: 17327088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Present chemotherapy of tuberculosis.
    O'Brien RJ
    Semin Respir Infect; 1989 Sep; 4(3):216-24. PubMed ID: 2512603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.